Leadership Overview
Indoco Remedies has 8 executives leading key functions including finance, marketing, corporate affairs, and sales.
Driven by a commitment to pharmaceutical excellence, Indoco Remedies operates as a fully integrated, research-oriented entity specializing in formulations and active pharmaceutical ingredients, impacting global health markets.
Driven by a commitment to pharmaceutical excellence, Indoco Remedies operates as a fully integrated, research-oriented entity specializing in formulations and active pharmaceutical ingredients, impacting global health markets.
Leadership Roles at Indoco Remedies
Pramod Ghorpade - President, Finance & Group Chief Financial Officer
Pramod Ghorpade, the President, Finance & Group Chief Financial Officer at Indoco Remedies, directs the company's comprehensive financial strategy and operations. Ghorpade oversees all fiscal planning, budgeting, and financial reporting, ensuring robust financial health and compliance across the organization. This leadership position involves managing capital allocation, investment strategies, and risk management to support Indoco Remedies' growth objectives in the pharmaceutical sector. The Group Chief Financial Officer also guides treasury functions and stakeholder relations, maintaining transparency and trust with investors and financial institutions. By optimizing financial performance, Pramod Ghorpade directly contributes to the company's ability to fund research, development, and manufacturing of formulations and APIs. Ghorpade's oversight ensures the financial infrastructure effectively supports Indoco Remedies' integrated business model and its market expansion across India and internationally.
Vilas Nagare - President, Corporate Affairs Mergers & Acquisitions
Vilas Nagare, the President, Corporate Affairs Mergers & Acquisitions at Indoco Remedies, spearheads strategic initiatives related to corporate development and expansion. Nagare leads the identification, evaluation, and execution of mergers and acquisitions that align with Indoco Remedies' long-term growth objectives. This critical role involves navigating complex deal structures, conducting due diligence, and integrating acquired entities seamlessly into the existing business framework. Vilas Nagare also manages key corporate relationships and ensures compliance with all relevant corporate governance standards. By driving strategic partnerships and acquisitions, Nagare enhances Indoco Remedies' market position and expands its capabilities in the pharmaceutical sector. The President, Corporate Affairs Mergers & Acquisitions is instrumental in shaping the company's future through targeted growth opportunities.

Anant Rege - President
Anant Rege, the President at Indoco Remedies, provides overarching leadership and strategic direction for the company's integrated pharmaceutical operations. Rege guides the organization's mission to research, develop, and market high-quality formulations and active pharmaceutical ingredients (APIs). This executive role involves fostering a culture of innovation and operational excellence across all departments. Anant Rege ensures that Indoco Remedies remains at the forefront of pharmaceutical advancements, adapting to evolving market dynamics and regulatory landscapes. The President's vision is crucial for driving sustainable growth and expanding the company's global footprint. Rege's leadership ensures the cohesive execution of strategies that enhance Indoco Remedies' competitive advantage and commitment to improving healthcare outcomes worldwide.
Sunil Joshi - President, Finance & Company Secretary
Sunil Joshi, the President, Finance & Company Secretary at Indoco Remedies, manages the company's financial architecture and corporate governance framework. Joshi oversees financial planning, reporting, and compliance, ensuring adherence to all statutory and regulatory requirements. This dual role involves managing treasury operations, investor relations, and the legal aspects of corporate secretarial functions. Sunil Joshi ensures that Indoco Remedies maintains the highest standards of corporate governance, transparency, and ethical conduct. By providing robust financial oversight and strategic guidance on corporate matters, Joshi supports the company's operational integrity and long-term stability. The President, Finance & Company Secretary's expertise is vital for navigating the complex financial and legal landscape of the pharmaceutical industry.
Rajesh Usgaonker - President, Sales & Marketing
Rajesh Usgaonker, the President, Sales & Marketing at Indoco Remedies, directs the commercial strategy and execution for the company's pharmaceutical products. Usgaonker leads the sales teams in expanding market share for formulations and active pharmaceutical ingredients (APIs) across domestic and international territories. This role involves developing and implementing innovative marketing campaigns, identifying new business opportunities, and strengthening customer relationships within the healthcare sector. Rajesh Usgaonker ensures that sales and marketing efforts are closely aligned with product development and overall company objectives. By driving revenue growth and enhancing brand presence, Usgaonker significantly contributes to Indoco Remedies' market leadership. The President, Sales & Marketing's strategic vision is key to achieving commercial success and expanding the company's global reach.

Preeti Avesh - Mrketing
Preeti Avesh, the Mrketing at Indoco Remedies, drives the strategic direction for market penetration and brand development. Avesh focuses on identifying new market opportunities and enhancing the visibility of Indoco Remedies' product portfolio, which includes finished dosage forms and active pharmaceutical ingredients. This role involves crafting and executing comprehensive marketing campaigns that resonate with target audiences and healthcare professionals. The marketing leadership ensures alignment between product development and market demand, fostering strong customer relationships. By analyzing market trends and competitive landscapes, Preeti Avesh guides the company's efforts to expand its reach within the pharmaceutical industry. Avesh's initiatives are crucial for building brand equity and achieving sustained commercial success for Indoco Remedies' diverse range of pharmaceutical offerings.
Amod Kane - Senior Executive Manager
Amod Kane, the Senior Executive Manager at Indoco Remedies, manages critical operational functions that support the company's integrated pharmaceutical business. Kane oversees key processes related to the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs). This executive role involves ensuring operational efficiency, quality control, and adherence to regulatory standards across production lines. Amod Kane's responsibilities extend to optimizing supply chain logistics and resource allocation to meet market demands effectively. By driving operational excellence, Kane contributes directly to Indoco Remedies' capacity to deliver high-quality pharmaceutical products. The Senior Executive Manager plays a vital part in maintaining the company's reputation for reliability and innovation within the global pharma landscape.
Bhushan Deshmukh - Senior Executive Manager
Bhushan Deshmukh, the Senior Executive Manager at Indoco Remedies, directs significant operational aspects of the company's pharmaceutical manufacturing and marketing activities. Deshmukh focuses on enhancing production efficiency and ensuring the consistent quality of both finished dosage forms and active pharmaceutical ingredients (APIs). This leadership position involves overseeing departmental workflows, implementing process improvements, and managing resources to meet production targets. Bhushan Deshmukh plays a key part in maintaining Indoco Remedies' adherence to stringent international regulatory requirements. By optimizing manufacturing processes and supply chain coordination, Deshmukh directly supports the company's ability to serve diverse global markets. The Senior Executive Manager's contributions are vital for sustaining Indoco Remedies' reputation for excellence in pharmaceutical production.
Explore Leadership Teams in Manufacturing
AbbVie Inc. is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and health solutions that address some of the worlds most complex medical challenges. Headquartered in North Chicago, Illinois, the company operates internationally and focuses on advancing treatments that improve patient outcomes and overall quality of life. AbbVies scientific and commercial efforts are concentrated in several core therapeutic areas, including immunology, oncology, neuroscience, eye care, and medical aesthetics, along with other specialty areas where significant unmet medical needs exist. Through these focus areas, the company works to create therapies that help patients manage chronic, serious, and often life-altering diseases.
Company Leadership XY
CL
NR
MS
Samsung Biologics Co.,Ltd. engages in the contract development and manufacturing organization (CDMO) business for biopharmaceuticals products in South Korea, Europe, the United States, and internationally. The company operates in two segments, CDMO, and Biopharmaceutical Development and Commercialization. Its development services include discovery, cell line development, process development, and clinical manufacturing. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and support services; and quality assurance and control, as well as biosafety and analytical testing services. In addition, it engages in the research and commercialization of biosimilar drugs; development and manufacture of antibody-drug conjugates; and manufactures mammalian and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.
Company Leadership
BB
YK
TK
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat specific forms of advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan.
Company Leadership
CP
CO
GP
Revolution Medicines Inc is a pioneering biotechnology company committed to revolutionizing treatment for patients battling cancer. They are driven by a singular mission: the discovery, development, and delivery of innovative, targeted medicines, particularly focusing on what are known as RAS-addicted cancers, which represent a significant proportion of new human cancer diagnoses. The company has developed a groundbreaking tri-complex inhibitor platform to create a portfolio of RAS(ON) inhibitors, enabling a differentiated approach to target what was previously considered an undruggable molecular target in oncology. Through their tireless efforts and commitment to transformative science, they are building a deep pipeline of therapeutic candidates intended to change the standard of care for patients with these challenging diseases.
Company Leadership AS

SK